Analysts expect Orthopediatrics (NASDAQ:KIDS) to announce earnings per share of ($0.13) for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for Orthopediatrics’ earnings. The highest EPS estimate is ($0.06) and the lowest is ($0.17). The company is expected to issue its next quarterly earnings results on Monday, August 13th.
On average, analysts expect that Orthopediatrics will report full year earnings of ($0.76) per share for the current financial year, with EPS estimates ranging from ($0.90) to ($0.66). For the next fiscal year, analysts anticipate that the business will post earnings of ($0.20) per share, with EPS estimates ranging from ($0.26) to ($0.11). Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research firms that follow Orthopediatrics.
Orthopediatrics (NASDAQ:KIDS) last announced its quarterly earnings data on Monday, May 14th. The company reported ($0.24) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.30) by $0.06. The firm had revenue of $12.09 million during the quarter, compared to analysts’ expectations of $11.38 million.
In other news, insider David R. Bailey sold 30,231 shares of the company’s stock in a transaction on Friday, April 13th. The shares were sold at an average price of $17.92, for a total value of $541,739.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, General Counsel Daniel J. Gerritzen sold 11,145 shares of the company’s stock in a transaction on Friday, April 13th. The shares were sold at an average price of $17.92, for a total transaction of $199,718.40. The disclosure for this sale can be found here. In the last 90 days, insiders sold 70,847 shares of company stock valued at $1,269,578.
Institutional investors have recently modified their holdings of the company. Next Century Growth Investors LLC acquired a new position in shares of Orthopediatrics in the 4th quarter valued at $2,321,000. AWM Investment Company Inc. acquired a new position in shares of Orthopediatrics in the 4th quarter valued at $8,816,000. Monarch Partners Asset Management LLC acquired a new position in shares of Orthopediatrics in the 4th quarter valued at $339,000. Lombard Odier Asset Management USA Corp acquired a new position in shares of Orthopediatrics in the 4th quarter valued at $624,000. Finally, Driehaus Capital Management LLC acquired a new position in shares of Orthopediatrics in the 4th quarter valued at $7,682,000. Institutional investors and hedge funds own 33.20% of the company’s stock.
Shares of NASDAQ:KIDS traded up $0.38 during trading hours on Tuesday, reaching $19.68. The stock had a trading volume of 12,381 shares, compared to its average volume of 56,180. Orthopediatrics has a 1 year low of $14.00 and a 1 year high of $23.00. The company has a debt-to-equity ratio of 0.57, a current ratio of 6.24 and a quick ratio of 5.29.
Orthopediatrics Company Profile
OrthoPediatrics Corp. is a medical device company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. Its products includes PediLoc �, PediPlates �, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc � Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, RESPONSE Spine, Bandloc and Pediguard.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.